Adamed Group, which includes Adamed sp. z o.o., is a Polish pharmaceutical-biotechnological company. It was established from the ground up based on Polish scientific thought and unique patents. The company is a manufacturer of over 250 next-generation products, available both in the Polish market and to patients abroad in over 60 countries worldwide. Adamed has its representations in Russia, Spain, Kazakhstan, and Ukraine. Currently, it employs approximately 1600 people. For over 15 years, the company has been engaged in innovative research and development activities, forming research consortia with leading universities and scientific institutes, both domestically and internationally. The company's intellectual property is protected by several dozen patents.